UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004277
Receipt number R000004658
Scientific Title Theta-burst transcranial magnetic stimulation in the treatment of depression: A double-blind, randomized, placebo-controlled crossover trial
Date of disclosure of the study information 2010/10/01
Last modified on 2012/10/11 19:12:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Theta-burst transcranial magnetic stimulation in the treatment of depression: A double-blind, randomized, placebo-controlled crossover trial

Acronym

Theta-burst transcranial magnetic stimulation in the treatment of depression: A double-blind, randomized, placebo-controlled crossover trial

Scientific Title

Theta-burst transcranial magnetic stimulation in the treatment of depression: A double-blind, randomized, placebo-controlled crossover trial

Scientific Title:Acronym

Theta-burst transcranial magnetic stimulation in the treatment of depression: A double-blind, randomized, placebo-controlled crossover trial

Region

Japan


Condition

Condition

Major depressive disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate 1) the efficacy of intermittent theta-burst stimulation (iTBS) and continuous theta-burst stimulation (cTBS) over the prefrontal cortex in depression, 2) changes in biological markers associated with depression before and after theta-burst stimulation, and 3) changes in electroencephalography and polysomnography before and after theta-burst stimulation

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

HAMD, MADRS, and CGI at baseline, week 1, week 2, week 3, and week 4

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

iTBS or cTBS will be applied in the left and right prefrontal cortex.
Sham (1 week), Washout (3 weeks), Left TBS (1 week), Washout (3 weeks), Right TBS (1 week)

Interventions/Control_2

Left TBS (1 week), Washout (3 weeks), Right TBS (1 week), Washout (3 weeks), Sham (1 week)

Interventions/Control_3

Right TBS (1 week), Washout (3 weeks), Sham (1 week), Washout (3 weeks), Left TBS (1 week)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients with DSM-IV-TR of major depressive disorder
2)Patients scored greater than 18 on the HAMD
3)Patients have failed a minimum of 1 course of antidepressant medication in the current depressive episode

Key exclusion criteria

1)Severe suicidal idea
2)Neurological disorders/organic brain disorders
3)History of convulsive disorders
4)Drug or alcohol abuse/dependence
5)Implanted electronic devices/magnetic material
6)Severe physical diseases

Target sample size

18


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinsuke Kito

Organization

Kyorin University School of Medicine

Division name

Department of Neuropsychiatry

Zip code


Address

6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan

TEL

0422-47-5511

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shinsuke Kito

Organization

Kyorin University School of Medicine

Division name

Department of Neuropsychiatry

Zip code


Address

6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan

TEL

0422-47-5511

Homepage URL


Email

psychiat@ks.kyorin-u.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, Kyorin University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

杏林大学付属病院(東京)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 07 Month 05 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 09 Month 28 Day

Last modified on

2012 Year 10 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004658


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name